vs
Clipper Realty Inc.（CLPR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Clipper Realty Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.0倍（$37.1M vs $35.5M），Clipper Realty Inc.净利率更高（-30.4% vs -304.2%，领先273.8%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -2.6%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 1.8%）
Clipper Realty Inc.旗下Clipper Equity由大卫·比斯特里瑟和山姆·莱文森牵头成立，在美国纽约与新泽西州拥有超60栋物业，合计数千套住宅单元。该企业最为人熟知的事迹是曾在2007年2月出价13亿美元收购纽约布鲁克林的斯塔雷特城住宅区，该交易曾是当时全球规模最大的房地产交易之一。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CLPR vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.1M | $35.5M |
| 净利润 | $-11.3M | $-108.1M |
| 毛利率 | -5.2% | 59.8% |
| 营业利润率 | 21.8% | -304.8% |
| 净利率 | -30.4% | -304.2% |
| 营收同比 | -2.6% | 681.7% |
| 净利润同比 | -938.6% | 39.6% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $37.1M | $35.5M | ||
| Q3 25 | $37.7M | $5.2M | ||
| Q2 25 | $39.0M | $19.2M | ||
| Q1 25 | $39.4M | $14.7M | ||
| Q4 24 | $38.0M | $4.5M | ||
| Q3 24 | $37.6M | $26.1M | ||
| Q2 24 | $37.3M | $14.4M | ||
| Q1 24 | $35.8M | $13.8M |
| Q4 25 | $-11.3M | $-108.1M | ||
| Q3 25 | $-4.6M | $-162.3M | ||
| Q2 25 | $-1.4M | $-171.9M | ||
| Q1 25 | $-35.1M | $-202.5M | ||
| Q4 24 | $-1.1M | $-178.9M | ||
| Q3 24 | $-1.1M | $-95.8M | ||
| Q2 24 | $-1.7M | $-97.5M | ||
| Q1 24 | $-2.7M | $-91.4M |
| Q4 25 | -5.2% | 59.8% | ||
| Q3 25 | 23.6% | -183.8% | ||
| Q2 25 | 27.8% | -4.9% | ||
| Q1 25 | -34.5% | -48.0% | ||
| Q4 24 | 28.8% | -181.4% | ||
| Q3 24 | 28.6% | 53.7% | ||
| Q2 24 | 26.8% | 36.2% | ||
| Q1 24 | 25.4% | 19.1% |
| Q4 25 | 21.8% | -304.8% | ||
| Q3 25 | 23.6% | -3327.6% | ||
| Q2 25 | 27.7% | -916.8% | ||
| Q1 25 | -59.9% | -1297.9% | ||
| Q4 24 | 28.1% | -4042.4% | ||
| Q3 24 | 28.6% | -377.1% | ||
| Q2 24 | 26.8% | -697.4% | ||
| Q1 24 | 25.4% | -698.4% |
| Q4 25 | -30.4% | -304.2% | ||
| Q3 25 | -12.2% | -3135.3% | ||
| Q2 25 | -3.5% | -894.2% | ||
| Q1 25 | -89.1% | -1373.3% | ||
| Q4 24 | -2.9% | -3935.5% | ||
| Q3 24 | -2.9% | -367.5% | ||
| Q2 24 | -4.7% | -676.6% | ||
| Q1 24 | -7.5% | -662.4% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.8M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $-30.7M | $1.1B |
| 总资产 | $1.2B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $30.8M | $743.3M | ||
| Q3 25 | $26.1M | $659.8M | ||
| Q2 25 | $32.0M | $525.1M | ||
| Q1 25 | $21.3M | $500.5M | ||
| Q4 24 | $19.9M | $594.4M | ||
| Q3 24 | $18.6M | $427.6M | ||
| Q2 24 | $20.3M | $474.3M | ||
| Q1 24 | $21.9M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | $1.3B | $16.4M | ||
| Q4 24 | $1.3B | $19.0M | ||
| Q3 24 | $1.3B | $20.5M | ||
| Q2 24 | $1.2B | $22.9M | ||
| Q1 24 | $1.2B | — |
| Q4 25 | $-30.7M | $1.1B | ||
| Q3 25 | $-25.0M | $1.0B | ||
| Q2 25 | $-21.9M | $919.1M | ||
| Q1 25 | $-20.1M | $933.9M | ||
| Q4 24 | $-5.4M | $1.0B | ||
| Q3 24 | $-3.6M | $524.6M | ||
| Q2 24 | $-1.8M | $584.4M | ||
| Q1 24 | $279.0K | $401.2M |
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.3B | $1.4B | ||
| Q3 24 | $1.3B | $726.5M | ||
| Q2 24 | $1.3B | $775.9M | ||
| Q1 24 | $1.3B | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | 4396.73× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $22.6M | $-46.1M | ||
| Q3 25 | $1.4M | $-117.4M | ||
| Q2 25 | $8.4M | $-76.4M | ||
| Q1 25 | $6.7M | $-132.0M | ||
| Q4 24 | $31.9M | $-115.4M | ||
| Q3 24 | $6.3M | $-59.2M | ||
| Q2 24 | $8.8M | $-82.2M | ||
| Q1 24 | $6.3M | $-102.3M |
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | $-4.6M | $-133.8M | ||
| Q4 24 | $-37.9M | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | $-14.7M | $-109.0M |
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | -11.7% | -907.4% | ||
| Q4 24 | -99.5% | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | -41.1% | -789.9% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | 28.6% | 12.4% | ||
| Q4 24 | 183.3% | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | 58.6% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLPR
| Residential Segment | $30.8M | 83% |
| Commercial Real Estate | $6.2M | 17% |
RXRX
暂无分部数据
